Literature DB >> 22770373

Rising incidence of adenocarcinoma of the lung in Canada.

Xiaohong Jiang1, Margaret de Groh, Shiliang Liu, Hongbo Liang, Howard Morrison.   

Abstract

BACKGROUND/AIMS: This study examines temporal trends in incidence of lung cancer in 1972-2007, temporal trends in histological types of lung cancer in 1988-2007, and age-period-cohort effects on the incidence rates of lung cancer in Canada.
METHODS: Using incidence data for 1972-2007, we calculated the three-year period rates and annual percentage change (APC): from 1988 to 2007 we were able to do this by histological types. We used age-period-cohort modelling to estimate underlying effects on the observed trends in incidence of adenocarcinoma of the lung.
RESULTS: In Canada, age-adjusted incidence rates have increased by 263% in women and 4% in men from 1972 to 2007. Annual percent change in age-adjusted rates for women by histological type from 1988 to 2007 were 2.2% for adenocarcinoma, -0.9% for squamous cell carcinoma and -0.4% for small cell carcinoma. Age-adjusted rates decreased for men over the same 20 years: adenocarcinoma (APC: -0.6%), squamous cell carcinoma (APC: -4.2%) and small cell carcinoma (APC: -3.2%) in men. Age-specific incidence rates increased most rapidly for adenocarcinoma in those aged 75+ years (APC: women 4.3%; APC: men 1.1%). The age-period-cohort modelling suggested that the risk of being diagnosed with adenocarcinoma is decreasing in men and will be decreasing slowly in women.
CONCLUSIONS: The adenocarcinoma incidence trends observed are consistent with smoking trends, however, the relative risk with smoking is lower for adenocarcinoma than for squamous cell carcinoma and small cell carcinoma. This suggests that other exposures may play a role in adenocarcinoma incidence, such as exposure to environmental carcinogens. Crown
Copyright © 2012. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22770373     DOI: 10.1016/j.lungcan.2012.06.002

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

1.  Cigarette smoke cadmium breakthrough from traditional filters: implications for exposure.

Authors:  R Steven Pappas; Mark R Fresquez; Clifford H Watson
Journal:  J Anal Toxicol       Date:  2014-10-13       Impact factor: 3.367

2.  Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011-2015.

Authors:  Pingli Wang; Jixia Zou; Jingni Wu; Chengyan Zhang; Chengxi Ma; Juan Yu; You Zhou; Baizhou Li; Kai Wang
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  Clinical epidemiology of gastric cancer in Hehuang valley of China: a 10-year epidemiological study of gastric cancer.

Authors:  Su Yan; Bin Li; Zhen-Zhong Bai; Jun-Qi Wu; Da-Wei Xie; Ying-Cai Ma; Xu-Xiang Ma; Jun-Hui Zhao; Xin-Jian Guo
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides.

Authors:  Jheelam Banerjee; Arokya M S Papu John; Hildegard M Schuller
Journal:  Int J Cancer       Date:  2015-07-02       Impact factor: 7.396

Review 5.  Worldwide trend of increasing primary adenocarcinoma of the lung.

Authors:  Haruhiko Nakamura; Hisashi Saji
Journal:  Surg Today       Date:  2013-06-11       Impact factor: 2.549

6.  Time Trends in Epidemiologic Characteristics and Imaging Features of Lung Adenocarcinoma: A Population Study of 21,113 Cases in China.

Authors:  Li Zhang; Meng Li; Ning Wu; Yuheng Chen
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

7.  An international contrast of rates of placental abruption: an age-period-cohort analysis.

Authors:  Cande V Ananth; Katherine M Keyes; Ava Hamilton; Mika Gissler; Chunsen Wu; Shiliang Liu; Miguel Angel Luque-Fernandez; Rolv Skjærven; Michelle A Williams; Minna Tikkanen; Sven Cnattingius
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

8.  MicroRNA-216b-3p inhibits lung adenocarcinoma cell growth via regulating PDZ binding kinase/T-LAK-cell-originated protein kinase.

Authors:  Yaqin Chai; Huijun Xue; Yanmei Wu; Xiaomei Du; Zhuohong Zhang; Yinliang Zhang; Lili Zhang; Shuanbao Zhang; Zhiguo Zhang; Zhiwen Xue
Journal:  Exp Ther Med       Date:  2018-04-02       Impact factor: 2.447

9.  Epidemiological characteristics and risk factors of lung adenocarcinoma: A retrospective observational study from North China.

Authors:  Daojuan Li; Jin Shi; Xiaoping Dong; Di Liang; Jing Jin; Yutong He
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

10.  Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer.

Authors:  Dong Soo Lee; Yeon Sil Kim; Chul Seung Kay; Sung Hwan Kim; Chang Dong Yeo; Jin Woo Kim; Seung Joon Kim; Young Kyoon Kim; Yoon Ho Ko; Jin Hyoung Kang; Kyo Young Lee
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.